Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population-Reference-Cited by-同舟云学术

Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population

Published:2009-11 Issue:11 Volume:20 Page:1803-1812
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Castellano D.,del Muro X. Garcia,Pérez-Gracia J.L.,González-Larriba J.L.,Abrio M.V.,Ruiz M.A.,Pardo A.,Guzmán C.,Cerezo S. Díaz,Grande E.

Funder

Pfizer Spain

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/11/1803/19445771/mdp067.pdf

Reference25 articles.

1. Food and Drug Administration (FDA)Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labelling Claimshttp://www.fda.gov/cder/guidance/index.html. (13 March 2008, date last accessed)

2. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med.,2007

3. Impaired health-related quality of life in chronic hepatitis C: the how, but not the why;Koff;Hepatology,1999

4. Invited Paper D. Industry perspectives regarding outcomes research in oncology;Copley-Merriman,2005

5. FACIT. Functional Assessment of Chronic Illness Therapy http://www.facit.org/qview/qlist.aspx. (15 March 2008, date last accessed)

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2023-05-04

2. Comparison of Chief Complaints and Patient-Reported Symptoms of Treatment-Naive Lung Cancer Patients Before Surgery;Patient Preference and Adherence;2021-05

3. Targeted therapy for metastatic renal cell carcinoma;Cochrane Database of Systematic Reviews;2020-10-14

4. Role and relevance of quality indicators in the selection of first-line treatment of patients with metastatic renal cell carcinoma: a position paper of the MeetURO Group;Future Oncology;2019-08

5. Tumor-induced neoangiogenesis and receptor tyrosine kinases – Mechanisms and strategies for acquired resistance;Biochimica et Biophysica Acta (BBA) - General Subjects;2019-07